2023 Q2 Form 10-Q Financial Statement

#000170471523000023 Filed on May 08, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1 2022 Q1
Revenue $858.4M $911.2M $1.072B
YoY Change -35.77% -14.99% 177.53%
Cost Of Revenue $583.5M $539.1M $555.3M
YoY Change -6.77% -2.91% 59.85%
Gross Profit $274.9M $372.1M $516.6M
YoY Change -61.32% -27.98% 1231.56%
Gross Profit Margin 32.02% 40.83% 48.2%
Selling, General & Admin $17.51M $20.69M $15.09M
YoY Change -3.59% 37.16% 0.69%
% of Gross Profit 6.37% 5.56% 2.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $34.42M $29.42M $28.04M
YoY Change 2.81% 4.95% -1.42%
% of Gross Profit 12.52% 7.91% 5.43%
Operating Expenses $56.75M $20.69M $15.09M
YoY Change 212.56% 37.16% 0.69%
Operating Profit $218.1M $314.5M $453.1M
YoY Change -66.46% -30.59% -2845.67%
Interest Expense -$2.276M $1.720M $13.08M
YoY Change -143.62% -86.85% -27.28%
% of Operating Profit -1.04% 0.55% 2.89%
Other Income/Expense, Net -$874.0K -$1.319M -$12.46M
YoY Change -84.94% -89.42% -23.04%
Pretax Income $215.0M $313.2M $440.6M
YoY Change -66.65% -28.92% -1447.65%
Income Tax $33.60M $42.41M $39.62M
% Of Pretax Income 15.63% 13.54% 8.99%
Net Earnings $181.4M $270.8M $400.9M
YoY Change -68.41% -32.46% -1317.48%
Net Earnings / Revenue 21.13% 29.71% 37.4%
Basic Earnings Per Share $12.63 $17.74 $21.58
Diluted Earnings Per Share $12.16 $17.01 $20.52
COMMON SHARES
Basic Shares Outstanding 14.47M shares 15.17M shares 18.57M shares
Diluted Shares Outstanding 14.91M shares 15.92M shares 19.54M shares

Balance Sheet

Concept 2023 Q2 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $312.4M $222.5M $159.5M
YoY Change 93.16% 39.54% 72.94%
Cash & Equivalents $312.4M $222.5M $159.5M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $63.43M $57.05M $57.21M
YoY Change 9.51% -0.28% -48.04%
Inventory $270.5M $266.7M $161.8M
Prepaid Expenses
Receivables $432.0M $546.3M $636.2M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.078B $1.092B $1.015B
YoY Change -2.74% 7.68% 93.04%
LONG-TERM ASSETS
Property, Plant & Equipment $967.4M $944.9M $806.3M
YoY Change 17.69% 17.19% -1.49%
Goodwill
YoY Change
Intangibles $50.71M $52.91M $68.45M
YoY Change -19.12% -22.71% -18.75%
Long-Term Investments
YoY Change
Other Assets $261.5M $107.0M $96.67M
YoY Change 176.33% 10.64% -34.76%
Total Long-Term Assets $1.280B $1.257B $1.098B
YoY Change 15.54% 14.4% -4.16%
TOTAL ASSETS
Total Short-Term Assets $1.078B $1.092B $1.015B
Total Long-Term Assets $1.280B $1.257B $1.098B
Total Assets $2.358B $2.349B $2.113B
YoY Change 6.39% 11.17% 26.4%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $106.2M $122.7M $109.4M
YoY Change 5.21% 12.18% 11.76%
Accrued Expenses $113.9M $110.7M $223.2M
YoY Change -17.16% -50.43% 65.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.486M $3.562M $2.434M
YoY Change 80.9% 46.34% -91.72%
Total Short-Term Liabilities $295.7M $316.6M $360.9M
YoY Change -14.4% -12.28% 24.63%
LONG-TERM LIABILITIES
Long-Term Debt $7.761M $8.379M $248.9M
YoY Change 180.99% -96.63% -54.76%
Other Long-Term Liabilities $454.3M $18.51M $22.62M
YoY Change 2140.83% -18.17% -18.76%
Total Long-Term Liabilities $462.1M $18.51M $22.62M
YoY Change 2179.11% -18.17% -18.76%
TOTAL LIABILITIES
Total Short-Term Liabilities $295.7M $316.6M $360.9M
Total Long-Term Liabilities $462.1M $18.51M $22.62M
Total Liabilities $791.1M $800.5M $1.183B
YoY Change -11.76% -32.34% -21.2%
SHAREHOLDERS EQUITY
Retained Earnings $1.713B $1.539B $329.2M
YoY Change 91.16% 367.65% -183.66%
Common Stock $219.0K $218.0K $210.0K
YoY Change 1.39% 3.81% 1.45%
Preferred Stock
YoY Change
Treasury Stock (at cost) $130.1M
YoY Change 20.78%
Treasury Stock Shares
Shareholders Equity $1.567B $1.549B $929.8M
YoY Change
Total Liabilities & Shareholders Equity $2.358B $2.349B $2.113B
YoY Change 6.39% 11.17% 26.4%

Cashflow Statement

Concept 2023 Q2 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income $181.4M $270.8M $400.9M
YoY Change -68.41% -32.46% -1317.48%
Depreciation, Depletion And Amortization $34.42M $29.42M $28.04M
YoY Change 2.81% 4.95% -1.42%
Cash From Operating Activities $317.2M $177.4M $336.1M
YoY Change -31.92% -47.23% -1858.44%
INVESTING ACTIVITIES
Capital Expenditures $54.86M $74.25M -$28.15M
YoY Change -231.04% -363.8% 37.97%
Acquisitions
YoY Change
Other Investing Activities $11.45M -$12.00K $1.243M
YoY Change -111.26% -100.97% -7005.56%
Cash From Investing Activities -$43.41M -$27.89M -$3.552M
YoY Change -69.77% 685.22% -88.06%
FINANCING ACTIVITIES
Cash Dividend Paid $6.602M $85.98M $0.00
YoY Change
Common Stock Issuance & Retirement, Net $16.55M
YoY Change 2333.38%
Debt Paid & Issued, Net $438.0K $200.5M
YoY Change -99.78% 3738.04%
Cash From Financing Activities -163.5M -$231.5M -$219.7M
YoY Change -61.18% 5.35% 3330.67%
NET CHANGE
Cash From Operating Activities 317.2M $177.4M $336.1M
Cash From Investing Activities -43.41M -$27.89M -$3.552M
Cash From Financing Activities -163.5M -$231.5M -$219.7M
Net Change In Cash 110.3M -$81.96M $112.9M
YoY Change -211.39% -172.61% -304.23%
FREE CASH FLOW
Cash From Operating Activities $317.2M $177.4M $336.1M
Capital Expenditures $54.86M $74.25M -$28.15M
Free Cash Flow $262.4M $103.1M $364.3M
YoY Change -48.33% -71.69% 28247.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001704715
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P9M
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-38735
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
ALPHA METALLURGICAL RESOURCES, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-3015061
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
340 Martin Luther King Jr. Blvd.
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Bristol
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37620
CY2023Q1 dei City Area Code
CityAreaCode
423
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
573-0300
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock
CY2023Q1 dei Trading Symbol
TradingSymbol
AMR
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
14473756 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
906698000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1069738000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
4537000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
2226000 usd
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2022Q1 us-gaap Revenues
Revenues
1071964000 usd
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
539137000 usd
CY2022Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
555342000 usd
CY2023Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
29423000 usd
CY2022Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
28035000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5954000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5748000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
20692000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15086000 usd
CY2023Q1 amr Acquisition Related Obligations Changes In Fair Value Gain Loss
AcquisitionRelatedObligationsChangesInFairValueGainLoss
0 usd
CY2022Q1 amr Acquisition Related Obligations Changes In Fair Value Gain Loss
AcquisitionRelatedObligationsChangesInFairValueGainLoss
-9361000 usd
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1092000 usd
CY2022Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
628000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
596734000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
618898000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
314501000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
453066000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1720000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13083000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1518000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
184000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1361000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
631000 usd
CY2022Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1676000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1319000 usd
CY2022Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-12584000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313182000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
440482000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39591000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
400891000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.74
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.58
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.52
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18574026 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15916378 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19540642 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
400891000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
627000 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent
-775000 usd
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
139000 usd
CY2022Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-488000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
775000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
270283000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
401666000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222507000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
301906000 usd
CY2023Q1 us-gaap Short Term Investments
ShortTermInvestments
0 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
46052000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
369000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
239000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
546252000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
407210000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
266678000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
200574000 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6602000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
84748000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
24547000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
50448000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
49384000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1092487000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1114421000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
503403000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
491186000 usd
CY2023Q1 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
486721000 usd
CY2022Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
442645000 usd
CY2023Q1 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
83313000 usd
CY2022Q4 us-gaap Mineral Properties Accumulated Depletion
MineralPropertiesAccumulatedDepletion
77333000 usd
CY2023Q1 us-gaap Mineral Rights
MineralRights
458191000 usd
CY2022Q4 us-gaap Mineral Rights
MineralRights
451062000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
43236000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
53719000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
52905000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
55102000 usd
CY2023Q1 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
90428000 usd
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
105735000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50931000 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
28941000 usd
CY2023Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
10497000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
11378000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106957000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
103195000 usd
CY2023Q1 us-gaap Assets
Assets
2349117000 usd
CY2022Q4 us-gaap Assets
Assets
2312479000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3562000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3078000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
122738000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
106037000 usd
CY2023Q1 amr Acquisition Related Obligations Carrying Amount Current
AcquisitionRelatedObligationsCarryingAmountCurrent
381000 usd
CY2022Q4 amr Acquisition Related Obligations Carrying Amount Current
AcquisitionRelatedObligationsCarryingAmountCurrent
28254000 usd
CY2023Q1 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
189927000 usd
CY2022Q4 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
265256000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
316608000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
402625000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8379000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7897000 usd
CY2023Q1 amr Liability Defined Benefit Plan Postretirement Black Lung Health Coverage And Workers Compensation Noncurrent
LiabilityDefinedBenefitPlanPostretirementBlackLungHealthCoverageAndWorkersCompensationNoncurrent
185204000 usd
CY2022Q4 amr Liability Defined Benefit Plan Postretirement Black Lung Health Coverage And Workers Compensation Noncurrent
LiabilityDefinedBenefitPlanPostretirementBlackLungHealthCoverageAndWorkersCompensationNoncurrent
188247000 usd
CY2023Q1 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
102700000 usd
CY2022Q4 us-gaap Defined Benefit Pension Plan Liabilities Noncurrent
DefinedBenefitPensionPlanLiabilitiesNoncurrent
110836000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
144851000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
142048000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
24286000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10874000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18514000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20197000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
800542000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
882724000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
15500000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
218000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
217000 usd
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21800000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14800000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
21700000 shares
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
29423000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
813299000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
815442000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12650000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12162000 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
7000000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
6200000 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
791557000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
649061000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1539265000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1275319000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1548575000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1429755000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2349117000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2312479000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
400891000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
28035000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5748000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
534000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3679000 usd
CY2023Q1 amr Acquisition Related Obligations Changes In Fair Value Gain Loss
AcquisitionRelatedObligationsChangesInFairValueGainLoss
0 usd
CY2022Q1 amr Acquisition Related Obligations Changes In Fair Value Gain Loss
AcquisitionRelatedObligationsChangesInFairValueGainLoss
-9361000 usd
CY2023Q1 amr Gain Loss On Disposition Of Assets Including Cost Of Sales
GainLossOnDispositionOfAssetsIncludingCostOfSales
2363000 usd
CY2022Q1 amr Gain Loss On Disposition Of Assets Including Cost Of Sales
GainLossOnDispositionOfAssetsIncludingCostOfSales
636000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5954000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
3261000 usd
CY2022Q1 us-gaap Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash
PensionAndOtherPostretirementBenefitsExpenseReversalOfExpenseNoncash
-174000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14432000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
4676000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3034000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1182000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1748000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1361000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
126000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
135000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
152153000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Capital
IncreaseDecreaseInOperatingCapital
124087000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
177387000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
336125000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
74248000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
28146000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
3478000 usd
CY2022Q1 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
917000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
11919000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 usd
CY2023Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
141750000 usd
CY2022Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
50000 usd
CY2023Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
204660000 usd
CY2022Q1 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
28438000 usd
CY2023Q1 amr Payments To Acquire Equity Method Investments Capital Contributions
PaymentsToAcquireEquityMethodInvestmentsCapitalContributions
8124000 usd
CY2022Q1 amr Payments To Acquire Equity Method Investments Capital Contributions
PaymentsToAcquireEquityMethodInvestmentsCapitalContributions
3468000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-12000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1243000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27891000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3552000 usd
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
438000 usd
CY2022Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
200461000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
85979000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
0 usd
CY2023Q1 amr Payments For Repurchase Of Common Stock And Related Expenses
PaymentsForRepurchaseOfCommonStockAndRelatedExpenses
144919000 usd
CY2022Q1 amr Payments For Repurchase Of Common Stock And Related Expenses
PaymentsForRepurchaseOfCommonStockAndRelatedExpenses
21844000 usd
CY2023Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
222000 usd
CY2022Q1 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
2257000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-338000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
348000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-231452000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-219700000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-81956000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
112873000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
355394000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
182614000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273438000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295487000 usd
CY2023Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
1753000 usd
CY2022Q1 us-gaap Capital Lease Obligations Incurred
CapitalLeaseObligationsIncurred
736000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
13703000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
9529000 usd
CY2023Q1 amr Accrued Common Stock Repurchases
AccruedCommonStockRepurchases
5995000 usd
CY2022Q1 amr Accrued Common Stock Repurchases
AccruedCommonStockRepurchases
1996000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
6825000 usd
CY2022Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
0 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
222507000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
159455000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
17556000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50931000 usd
CY2022Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
118476000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
273438000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295487000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
546909000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
400891000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
775000 usd
CY2022Q1 amr Share Based Compensation Issuance Of Stock For Share Vesting And Stock Reissuance
ShareBasedCompensationIssuanceOfStockForShareVestingAndStockReissuance
1182000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
891000 usd
CY2022Q1 amr Treasury Stock Value Acquired Cost Method And Related Expenses
TreasuryStockValueAcquiredCostMethodAndRelatedExpenses
23840000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3039000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
929847000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1429755000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-488000 usd
CY2023Q1 amr Share Based Compensation Issuance Of Stock For Share Vesting And Stock Reissuance
ShareBasedCompensationIssuanceOfStockForShareVestingAndStockReissuance
3034000 usd
CY2023Q1 amr Treasury Stock Value Acquired Cost Method And Related Expenses
TreasuryStockValueAcquiredCostMethodAndRelatedExpenses
148973000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
1301000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2023Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
6825000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1548575000 usd
CY2023Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
ReclassificationsCertain immaterial amounts for the three months ended March 31, 2022 in the Condensed Consolidated Financials Statements and notes to the Condensed Consolidated Financials Statements have been recast to reclassify discontinued operations and present the related amounts within continuing operations as part of the All Other category.
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
110624000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
37250000 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
0 usd
CY2023Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
147874000 usd
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
270771000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
400891000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18574026 shares
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
17.74
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
21.58
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15266895 shares
CY2023Q1 amr Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
37404 shares
CY2023Q1 amr Shares Withheld Upon Conversion Of Convertible Securities
SharesWithheldUponConversionOfConvertibleSecurities
8514 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
18574026 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
158304 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
443273 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15916378 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19540642 shares
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
17.01
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
20.52
CY2023Q1 us-gaap Inventory Net
InventoryNet
266678000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
200574000 usd
CY2023Q1 amr Stock Repurchase Program Additional Authorized Repurchase Amount
StockRepurchaseProgramAdditionalAuthorizedRepurchaseAmount
200000000 usd
CY2023Q1 amr Shares Withheld Upon Conversion Of Convertible Securities Reclassified As Treasury Stock Value
SharesWithheldUponConversionOfConvertibleSecuritiesReclassifiedAsTreasuryStockValue
1075000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
744845 shares
CY2023Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
1200000000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
4414451 shares
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
654468000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
654335000 usd
CY2023Q1 amr Stock Repurchase Program Expenses
StockRepurchaseProgramExpenses
133000 usd
CY2023Q1 amr Stock Repurchase Program Excise Tax
StockRepurchaseProgramExciseTax
1199000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44
CY2023Q1 amr Dividend Equivalent
DividendEquivalent
223000 usd
CY2023Q1 amr Deposits Dividends
DepositsDividends
6602000 usd
CY2016Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
810811 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
45.086
CY2023Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
44.972
CY2022Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
1.20 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
159668 shares
CY2023Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
191602 shares
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
24959000 usd
CY2022Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
856572 shares
CY2022Q1 amr Stock Issued During Period Shares Exercise Of Warrants
StockIssuedDuringPeriodSharesExerciseOfWarrants
64861 shares
CY2022Q1 amr Shares Withheld Upon Conversion Of Convertible Securities
SharesWithheldUponConversionOfConvertibleSecurities
91 shares
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
55739000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
69458000 usd
CY2023Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
11651000 usd
CY2022Q4 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
11651000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
9664000 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
9664000 usd
CY2023Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
30820000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
36543000 usd
CY2022Q4 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
36963000 usd
CY2023Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
6824000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
86118000 usd
CY2023Q1 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
14898000 usd
CY2022Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2023Q1 amr Accrued Transportation Costs Current
AccruedTransportationCostsCurrent
12440000 usd
CY2022Q4 amr Accrued Transportation Costs Current
AccruedTransportationCostsCurrent
7181000 usd
CY2023Q1 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
11348000 usd
CY2022Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
19262000 usd
CY2023Q1 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
189927000 usd
CY2022Q4 amr Accrued Liabilities And Other Liabilities Current
AccruedLiabilitiesAndOtherLiabilitiesCurrent
265256000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
6972000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
6179000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
4969000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
4796000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
11941000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Including Current Maturities
LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities
10975000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3562000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
3078000 usd
CY2023Q1 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
8379000 usd
CY2022Q4 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
7897000 usd
CY2023Q1 amr Acquisition Related Obligations Carrying Amount Current
AcquisitionRelatedObligationsCarryingAmountCurrent
381000 usd
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
46052000 usd
CY2022Q4 us-gaap Restricted Investments Noncurrent
RestrictedInvestmentsNoncurrent
105735000 usd
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
24547000 usd
CY2023Q1 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
50931000 usd
CY2022Q4 amr Acquisition Related Obligations Carrying Amount Current
AcquisitionRelatedObligationsCarryingAmountCurrent
28254000 usd
CY2022Q4 us-gaap Asset Retirement Obligation
AssetRetirementObligation
179011000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
31000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Liabilities Settled
AssetRetirementObligationLiabilitiesSettled
3963000 usd
CY2023Q1 us-gaap Asset Retirement Obligation
AssetRetirementObligation
181394000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Current
AssetRetirementObligationCurrent
36543000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
144851000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
313182000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39591000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
440482000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
50931000 usd
CY2022Q4 us-gaap Restricted Cash
RestrictedCash
53488000 usd
CY2023Q1 us-gaap Restricted Cash Current
RestrictedCashCurrent
0 usd
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
28941000 usd
CY2023Q1 us-gaap Restricted Investments
RestrictedInvestments
90428000 usd
CY2022Q4 us-gaap Restricted Investments
RestrictedInvestments
105735000 usd
CY2023Q1 us-gaap Deposit Assets
DepositAssets
7472000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
86111000 usd
CY2023Q1 us-gaap Deposits Assets Current
DepositsAssetsCurrent
6602000 usd
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
84748000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
870000 usd
CY2022Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
1363000 usd
CY2023Q1 amr Deposits Dividends
DepositsDividends
6602000 usd
CY2022Q4 amr Deposits Dividends
DepositsDividends
84748000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2023Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
29423000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2023Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
354415000 usd
CY2023Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
74248000 usd
CY2022Q1 us-gaap Revenues
Revenues
1071964000 usd
CY2022Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
28035000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5748000 usd
CY2022Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
503661000 usd
CY2022Q1 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
28146000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
270771000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1720000 usd
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1518000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42411000 usd
CY2023Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
29423000 usd
CY2023Q1 amr Noncash Allocated Sharebased Compensation Expense
NoncashAllocatedSharebasedCompensationExpense
3034000 usd
CY2023Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
6377000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2197000 usd
CY2023Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
354415000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
400891000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
13083000 usd
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
184000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
39591000 usd
CY2022Q1 amr Depreciation Depletion And Amortization Excluding Acquired Intangibles
DepreciationDepletionAndAmortizationExcludingAcquiredIntangibles
28035000 usd
CY2022Q1 amr Noncash Allocated Sharebased Compensation Expense
NoncashAllocatedSharebasedCompensationExpense
1182000 usd
CY2022Q1 amr Acquisition Related Obligations Changes In Fair Value Gain Loss
AcquisitionRelatedObligationsChangesInFairValueGainLoss
-9361000 usd
CY2022Q1 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
5954000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5748000 usd
CY2022Q1 amr Adjusted Earnings Before Income Tax Interest Depreciation And Amortization
AdjustedEarningsBeforeIncomeTaxInterestDepreciationAndAmortization
503661000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
906698000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1069738000 usd
CY2023Q1 us-gaap Revenues
Revenues
911235000 usd
CY2022Q1 us-gaap Revenues
Revenues
1071964000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.44

Files In Submission

Name View Source Status
amr-20230331_cal.xml Edgar Link unprocessable
0001704715-23-000023-index-headers.html Edgar Link pending
0001704715-23-000023-index.html Edgar Link pending
0001704715-23-000023.txt Edgar Link pending
0001704715-23-000023-xbrl.zip Edgar Link pending
a3312023exhibit31.htm Edgar Link pending
a3312023exhibit32.htm Edgar Link pending
a3312023exhibit95.htm Edgar Link pending
amr-20230331.htm Edgar Link pending
amr-20230331.xsd Edgar Link pending
amr-20230331_g1.jpg Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
amr-20230331_def.xml Edgar Link unprocessable
amr-20230331_lab.xml Edgar Link unprocessable
amr-20230331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
amr-20230331_htm.xml Edgar Link completed
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending